Search

Your search keyword '"Giannini, Francesco"' showing total 36 results
Start Over Author "Giannini, Francesco" Publisher wiley-blackwell
36 results on '"Giannini, Francesco"'

1. Transcatheter Mitral Valve Repair With the MitraClip Device for Prior Mitral Valve Repair Failure: Insights From the GIOTTO-FAILS Study.

Author

Giordano, Arturo, Ferraro, Paolo, Finizio, Filippo, Corcione, Nicola, Cimmino, Michele, Biondi-Zoccai, Giuseppe, Denti, Paolo, Popolo Rubbio, Antonio, Petronio, Anna Sonia, Bartorelli, Antonio L., Mongiardo, Annalisa, Giordano, Salvatore, De Felice, Francesco, Adamo, Marianna, Montorfano, Matteo, Baldi, Cesare, Tarantini, Giuseppe, Giannini, Francesco, Ronco, Federico, and Monteforte, Ida

Published
2024
Full Text
View/download PDF

6. Clinical outcomes of left atrial appendage occlusion in patients with previous intracranial or gastrointestinal bleeding: Insights from the LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) International Multicenter Registry

Author

Gallo, Francesco, Ronco, Federico, D'Amico, Gianpiero, Della Rocca, Domenico G., Mazzone, Patrizio, Bordignon, Stefano, Casu, Gavino, Giannini, Francesco, Berti, Sergio, Horton, Rodney P., D'Angelo, Giuseppe, Urbanek, Lukas, Merella, Pierluigi, Ruggiero, Rossella, Romeo, Maria Rita, Bosica, Francesco, Schmidt, Boris, Atzori, Enrico, Barbierato, Marco, and Natale, Andrea

Published
2023
Full Text
View/download PDF

10. Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.

Author

Cortese, Bernardo, de la Torre Hernandez, Jose M., Lanocha, Magdalena, Ielasi, Alfonso, Giannini, Francesco, Campo, Gianluca, D'Ascenzo, Fabrizio, Latini, Roberto A., Krestianinov, Oleg, Alfonso, Fernando, Trani, Carlo, Prati, Francesco, Linares, Jose A., Sardella, Gennaro, Wlodarczak, Adrian, Viganò, Elena, Camarero, Tamara Garcia, Stella, Pieter, Sozykin, Alexander, and Fineschi, Massimo

Published
2022
Full Text
View/download PDF

12. Computed tomography analysis of coronary ostia location following valve‐in‐valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access.

Author

Khokhar, Arif A., Laricchia, Alessandra, Ponticelli, Francesco, Kim, Won‐Keun, Gallo, Francesco, Regazzoli, Damiano, Toselli, Marco, Sticchi, Alessandro, Ruggiero, Rossella, Cereda, Alberto, Zlahoda‐Huzior, Adriana, Fisicaro, Andrea, Gardi, Ilja, Mangieri, Antonio, Reimers, Bernhard, Dudek, Dariusz, Colombo, Antonio, and Giannini, Francesco

Published
2021
Full Text
View/download PDF

16. Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta‐analysis.

Author

Saglietto, Andrea, D'Ascenzo, Fabrizio, Errigo, Daniele, Leonardi, Sergio, Dewilde, Willem J, Conrotto, Federico, Omedè, Pierluigi, Montefusco, Antonio, Angelini, Filippo, De Filippo, Ovidio, Bianco, Matteo, Gallone, Guglielmo, Bruno, Francesco, Zaccaro, Lorenzo, Giannini, Francesco, Latib, Azeem, Colombo, Antonio, Costa, Francesco, and De Ferrari, Gaetano Maria

Published
2021
Full Text
View/download PDF

17. Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.

Author

Giannini, Francesco, Pagnesi, Matteo, Campo, Gianluca, Donahue, Michael, Ferri, Luca A., Briguori, Carlo, Stefanini, Giulio G., Scardala, Raffaele, Sardella, Gennaro, De Rosa, Salvatore, Figini, Filippo, Monello, Alberto, Pastormerlo, Luigi E., Testa, Luca, Nicolino, Annamaria, Ielasi, Alfonso, Durante, Alessandro, Leone, Angelo, Tzanis, Giorgios, and Mangieri, Antonio

Published
2021
Full Text
View/download PDF

19. Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?

Author

Rapezzi, Claudio, Giannini, Francesco, and Campo, Gianluca

Subjects
*CARDIAC amyloidosis, *HEART valve prosthesis implantation, *AORTIC stenosis, *TRANSTHYRETIN, *MAGNETIC resonance imaging
Abstract

Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. B This article refers to 'Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis' by H. Rosenblum I et al i ., published in this issue on pages 250-258. b The topic of coexisting aortic stenosis (AS) and cardiac amyloidosis (CA) has become a classic of contemporary cardiology due to the spread of transcatheter aortic valve replacement (TAVR) as a treatment for AS and the wide availability of bone scintigraphy as a non-invasive diagnostic standard for transthyretin-related amyloidosis (ATTR). [Extracted from the article]

Published
2021
Full Text
View/download PDF

25. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.

Author

Giannini, Francesco, Latib, Azeem, Montorfano, Matteo, Ruparelia, Neil, Romano, Vittorio, Longoni, Matteo, Ferri, Luca, Jabbour, Richard, Mangieri, Antonio, Regazzoli, Damiano, Ancona, Marco, Buzzatti, Nicola, Azzalini, Lorenzo, Tanaka, Akihito, Agricola, Eustachio, Chieffo, Alaide, Alfieri, Ottavio, and Colombo, Antonio

Published
2018
Full Text
View/download PDF

27. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.

Author

Giannini, Francesco, Latib, Azeem, Ancona, Marco B., Costopoulos, Charis, Ruparelia, Neil, Menozzi, Alberto, Castriota, Fausto, Micari, Antonio, Cremonesi, Alberto, De Felice, Francesco, Marchese, Alfredo, Tespili, Maurizio, Presbitero, Patrizia, Sgueglia, Gregory A., Buffoli, Francesca, Tamburino, Corrado, Varbella, Ferdinando, and Colombo, Antonio

Published
2017
Full Text
View/download PDF

33. Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations.

Author

Costopoulos, Charis, Latib, Azeem, Naganuma, Toru, Sticchi, Alessandro, Ferrarello, Santo, Regazzoli, Damiano, Chieffo, Alaide, Figini, Filippo, Carlino, Mauro, Montorfano, Matteo, Naim, Charbel, Kawaguchi, Masanori, Gerasimou, Argyrios, Giannini, Francesco, Godino, Cosmo, and Colombo, Antonio

Published
2014
Full Text
View/download PDF

35. Acute Reduction in Left Ventricular Function Following Transcatheter Mitral Edge-to-Edge Repair.

Author

Perl L, Kheifets M, Guido A, Agricola E, Denti P, Wild MG, Praz F, Rubbio AP, Bedogni F, De Marco F, Beeri R, Shuvy M, Melillo F, Montorfano M, Freixa X, de la Fuente Mancera JC, Giordano A, Finizio F, Van Mieghem NM, Ooms JFW, Fam N, O'Connor C, Toggweiler S, Levi A, Shapira Y, Schwartzenberg S, Pidello S, D'Ascenzo F, Angelini F, Haberman D, Crimi G, Porto I, Cozzi O, Giannini F, Tarantini G, Maisano F, and Kornowski R

Subjects
Humans, Ventricular Function, Left, Stroke Volume, Mitral Valve diagnostic imaging, Mitral Valve surgery, Treatment Outcome, Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation methods
Abstract

Background Little is known about the impact of transcatheter mitral valve edge-to-edge repair on changes in left ventricular ejection fraction (LVEF) and the effect of an acute reduction in LVEF on prognosis. We aimed to assess changes in LVEF after transcatheter mitral valve edge-to-edge repair for both primary and secondary mitral regurgitation (PMR and SMR, respectively), identify rates and predictors of LVEF reduction, and estimate its impact on prognosis. Methods and Results In this international multicenter registry, patients with both PMR and SMR undergoing transcatheter mitral valve edge-to-edge repair were included. We assessed rates of acute LVEF reduction (LVEFR), defined as an acute relative decrease of >15% in LVEF, its impact on all-cause mortality, major adverse cardiac event (composite end point of all-cause death, mitral valve surgery, and residual mitral regurgitation grade ≥2), and LVEF at 12 months, as well as predictors for LVEFR. Of 2534 patients included (727 with PMR, and 1807 with SMR), 469 (18.5%) developed LVEFR. Patients with PMR were older (79.0±9.2 versus 71.8±8.9 years; P <0.001) and had higher mean LVEF (54.8±14.0% versus 32.7±10.4%; P <0.001) at baseline. After 6 to 12 months (median, 9.9 months; interquartile range, 7.8-11.9 months), LVEF was significantly lower in patients with PMR (53.0% versus 56.0%; P <0.001) but not in patients with SMR. The 1-year mortality was higher in patients with PMR with LVEFR (16.9% versus 9.7%; P <0.001) but not in those with SMR ( P =0.236). LVEF at baseline (odds ratio, 1.03 [95% CI, 1.01-1.05]; P =0.002) was predictive of LVEFR for patients with PMR, but not those with SMR ( P =0.092). Conclusions Reduction in LVEF is not uncommon after transcatheter mitral valve edge-to-edge repair and is correlated with worsened prognosis in patients with PMR but not patients with SMR. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT05311163.

Published
2023
Full Text
View/download PDF

36. The influence of metabolic syndrome in heart valve intervention. A multi-centric study.

Author

Moscarelli M, Paparella D, Angelini GD, Giannini F, Contegiacomo G, Marchese A, Nasso G, Albertini A, Fattouch K, and Speziale G

Subjects
Humans, Risk Factors, Treatment Outcome, Aortic Valve surgery, Postoperative Complications etiology, Heart Valve Prosthesis Implantation adverse effects, Aortic Valve Stenosis surgery, Metabolic Syndrome complications, Metabolic Syndrome surgery, Transcatheter Aortic Valve Replacement adverse effects
Abstract

Background: The effect of metabolic syndrome (MetS), defined as insulin resistance along with two or more of: obesity, atherogenic dyslipidaemia and elevated blood pressure, on postoperative complications after isolated heart valve intervention remains controversial. We hypothesized that MetS may negatively influence the postoperative course in these patients., Methods: Patients from 10 cardiac units who underwent isolated valve intervention (mitral ± $\pm $  tricuspid repair/replacement (mitral valve surgery [MVS]) or surgical aortic valve replacement (SAVR), or transcatheter aortic valve replacement (TAVR) were included. MetS was defined according to the World Health Organization criteria. Primary outcome was in-hospital mortality and overall postoperative length of stay (LOS). Relevant postoperative complications were also recorded., Results: From 2010 to 2019, 17,283 patients underwent valve intervention. The MVS, SVAR, and TAVR accounted for the 39.4%, 48.2%, and 12.3% respectively of the whole. MetS compared to no-MetS was associated to higher mortality in the MVS group (6.5% vs. 2%, p < .001), but not in the SAVR and TAVR group. In both surgical cohorts, MetS was associated with increased complications including red blood cells transfusion, renal failure, mechanical ventilation time, intensive care and overall postoperative LOS (11 (9) vs. 10 (6), p < .001 and 10 (6) versus 10 (5) days, p = .002, MVS and [SAVR]). No differences were found in the TAVR cohort, with similar mortality and complications., Conclusion: MetS was associated to more postoperative complications, with higher mortality in the MVS group. In the TAVR cohort, postoperative complications and mortality rate did not differ between patients with and without MetS, however LOS was longer in the MetS group., (© 2022 Wiley Periodicals LLC.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results